Deep Genomics

Deep Genomics

AI-driven drug development for genetic conditions

About Deep Genomics

Simplify's Rating
Why Deep Genomics is rated
A-
Rated B on Competitive Edge
Rated A on Growth Potential
Rated A on Differentiation

Industries

AI & Machine Learning

Biotechnology

Company Size

51-200

Company Stage

Series C

Total Funding

$236.8M

Headquarters

Toronto, Canada

Founded

2014

Overview

Deep Genomics focuses on drug development in the biotechnology sector by utilizing artificial intelligence to explore RNA biology and discover potential therapies for genetic conditions. The company's main product, the AI Workbench, employs data-driven predictions to identify new drug targets. This tool has evolved over time, with versions that enhance its ability to target various genetic mechanisms and diseases. Deep Genomics differentiates itself from competitors by its specific focus on RNA splicing and its systematic approach to drug discovery, which includes licensing its findings to pharmaceutical companies and research institutions. The goal of Deep Genomics is to accelerate the drug development process and improve treatment options for patients suffering from genetic disorders.

Simplify Jobs

Simplify's Take

What believers are saying

  • Secured $180M funding to expand AI workbench and advance clinical programs by 2023.
  • AI-driven precision medicine aligns with growing personalized medicine trend.
  • AI Workbench 2.0 expanded mechanisms for increased expression in 2020.

What critics are saying

  • Competition from genomics startups like Element Biosciences with innovative sequencing technologies.
  • Dependency on external capital, as shown by recent $180M Series C funding.
  • New CEO Brian O'Callaghan may lead to strategic shifts impacting trajectory.

What makes Deep Genomics unique

  • Deep Genomics uses AI to unravel RNA biology for drug development.
  • AI Workbench 3.0 targets complex genetic diseases with expanded mechanisms.
  • BigRNA model uncovers RNA disease mechanisms and candidate therapeutics.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$236.8M

Above

Industry Average

Funded Over

4 Rounds

Notable Investors:
Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Above Average

Industry standards

$50M
$50M
Medium
$62M
SeatGeek
$100M
Oura
$180M
Deep Genomics

Benefits

Company Equity

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

↑ 1%

1 year growth

↑ 1%

2 year growth

↑ 2%
Medium
Jun 10th, 2025
Deep Genomics secures $180M for AI drug discovery

Deep Genomics, a Canadian biotech company, closed a $180 million Series C funding round led by Softbank, with investments from CPPIB, Fidelity, and others. The company, supported by Amplitude Ventures, uses AI to revolutionize drug discovery, focusing on RNA therapeutics. The funding will expand their AI workbench and pipeline, aiming to advance four programs into the clinic by 2023.

Labiotech
Jan 30th, 2025
Seven Genomics Startups To Look Out For

Newsletter Signup - Under Article / In Page"*" indicates required fields Precision medicine is a kind of treatment strategy that is tailored to individual patients, most of which is dependent on their genetic makeup. Genomics, which deals with the mapping of genomes, is a booming industry that aims to advance precision medicine to address a host of diseases. You may have heard of the big names in the business, like Illumina, Oxford Nanopore Technology, and Thermo Fisher Scientific. But there are a number of genomics startups that have sprouted up in the past decade or so to strengthen their sequencing technologies to aid in disease prevention and treatment. Here are seven genome sequencing startups that are making their mark in the industry.Element BiosciencesFounded in 2017, Element Biosciences shot to fame fairly quickly after the launch of its lab services. Its benchtop sequencing instrument AVITI has a dual flow cell layout and individually addressable lanes and you can perform two parallel runs and operate each side independently. Its alternative model, AVITI LT, is a lower-cost, lower-throughput solution that brings next-generation sequencing (NGS) to more labs.The core components of Element’s sequencing tool include an Avidite base chemistry, which circularizes, copies, and rolls each strand into tightly bound polonies – tiny clusters of identical DNA molecules – without the use of PCR and fluorescent avidites that bind to each polony creating ultrastable complexes. It also employs rolling circle amplification, which is a process that uses a circular DNA template to create long single-stranded DNA molecules to avoid errors such as index hopping – when sequencing reads are incorrectly assigned to the wrong sample in a pool. Its sought-after technology is called LoopSeq, which prepares libraries for long-read sequencing on the short-read Element AVITI System

BioPharmaTrend
Dec 28th, 2023
7 Companies Building Foundation Models in Biology and Chemical Synthesis

For instance, Deep Genomics unveiled BigRNA, a pioneering AI foundation model for uncovering RNA biology and therapeutics.

BioWorld
Sep 28th, 2023
Deep Genomics announces AI foundation model for RNA

Deep Genomics Inc. has introduced its artificial intelligence (AI) foundation model for RNA, BigRNA, which enables discovery of disease mechanisms and candidate therapeutics.

BioSpace
Sep 27th, 2023
Deep Genomics Introduces the Most Advanced AI Foundation Model for RNA Disease Mechanisms and Candidate Therapeutics

Deep Genomics introduces the most advanced AI Foundation model for RNA disease mechanisms and candidate therapeutics.

Recently Posted Jobs

Sign up to get curated job recommendations

Deep Genomics is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

đź’ˇ
Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →